None listed
Conditions
Interventions
Drug : Patients receive target-controlled infusion of dexmedetomidine for sedation during surgery under spinal anesthesia.
Sponsors
Hallym University Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who were scheduled for elective surgery within 3 hours under spinal anaesthesia 2. Patient who with American Society of Anesthesiologists grades I-III 3. Patients with aged 19-70 year 4. Patients who voluntarily agreed to be enrolled to the clinical research and signed written informed consent
Exclusion criteria
Exclusion criteria: 1. Patients who has cardiovascular disease (arrthymia, ischemic heart disease, myocardical infarction, heart failure) 2. Patients who has neurovascular disease 3. Patients who has a history of drug use that could affect the central nervous system 4. Patients who has a history of adverse reactions to anesthetic agents 5. Pregnant female, or female who breast-feeds her baby 6. Other in-appropriative patients under the researcher's decision.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sedation level score using Modified Observer’s Assessment of Alertness/Sedation (MOAA/S); (1== does not respond to mild prodding or shaking; 2 = responds only after mild prodding or shaking; 3 = responds only after name is called loudly or repeatedly; 4 = lethargic response to name spoken in normal tone; 5 = responds readily to name spoken in normal tone) | — |
Secondary
| Measure | Time frame |
|---|---|
| Bispectral index;Heart rate;Blood pressure;oxygen saturation(SpO2) | — |
Countries
Korea, Republic of
Contacts
Public ContactKyung Mi Kim
Hallym University Medical Center
Outcome results
None listed